Core Insights - The Tibet Qizheng Tibetan Medicine Co., Ltd. won the "Outstanding Award" at the Ram Charan Management Practice Award for its case study on sustainable business models and governance practices [1] Sustainable Business Model - The company emphasizes the importance of biodiversity and environmental protection in the Qinghai-Tibet Plateau, having completed resource surveys for over 120 Tibetan medicinal materials and established standards for over 60 local varieties [2] - Qizheng has developed a functional base system covering wild nurturing, semi-wild planting, artificial breeding of rare and endangered medicinal materials, and industrialized planting, with a total area exceeding 500,000 acres [2] - The company respects the rights of indigenous people and has established a benefit-sharing mechanism, promoting low-carbon concepts and high-standard green production through smart factories [2] - Qizheng's production process is inherently low-pollution and generates less waste, and the company has implemented an environmental management system certified by national standards [2] - The Qizheng Foundation supports Tibetan medicine culture through various projects, creating a mutually beneficial ecosystem with stakeholders including patients, employees, and suppliers [2] Sustainable Governance Practices - Since 2012, the company has been systematically building a sustainable development management system, with plans to upgrade its ESG framework by 2025 [3] - The strategic "Five Trees" model integrates disease, health, technology, products, and brand into a comprehensive layout, ensuring seamless connection between strategy and operational plans [3] - The company enforces a "one-vote veto" system in product development, prohibiting the market introduction of any product relying on endangered or scarce resources without completed resource planning [3] - Qizheng is advancing organizational youthfulness and establishing a modern enterprise management system to attract and cultivate professional talent [3] - The founder of Qizheng received the inaugural Peter Drucker China Management Award in 2019 for promoting sustainable development principles in Tibetan medicine [3]

Core Insights - The Tibet Qizheng Tibetan Medicine Co., Ltd. won the "Outstanding Award" at the Ram Charan Management Practice Award for its case study on sustainable business models and governance practices [1] Sustainable Business Model - The company emphasizes the importance of biodiversity and environmental protection in the Qinghai-Tibet Plateau, having completed resource surveys for over 120 Tibetan medicinal materials and established standards for over 60 local varieties [2] - Qizheng has developed a functional base system covering wild nurturing, semi-wild planting, artificial breeding of rare and endangered medicinal materials, and industrialized planting, with a total area exceeding 500,000 acres [2] - The company respects the rights of indigenous people and has established a benefit-sharing mechanism, promoting low-carbon concepts and high-standard green production through smart factories [2] - Qizheng's production process is inherently low-pollution and generates less waste compared to chemical drugs, and it has implemented an environmental management system certified by ISO14001 and received a B-level certificate for environmental standardization [2] - The company promotes Tibetan medicine culture through initiatives like the Qizheng Foundation and the "Hundred Clinics Plan," fostering a mutually beneficial ecosystem with stakeholders [2] Sustainable Governance Practices - Since 2012, Qizheng has been systematically constructing a sustainable development management system, with plans to upgrade its ESG framework by 2025 [3] - The company has established a "Strategic Five Trees" model to create a comprehensive layout linking disease, health, technology, products, and brand, ensuring seamless integration of strategy and operational plans [3] - Qizheng enforces a "one-vote veto" system in product development, prohibiting the market introduction of any strategic products relying on endangered or scarce resources without completed resource planning [3] - The company is advancing organizational youthfulness and building a management foundation centered on modern corporate systems, ensuring that a professional team drives corporate development [3] - The founder of Qizheng, Lei Jufang, received the first Peter Drucker Management Award in China for his sustainable development practices in Tibetan medicine [3]

Core Insights - The Tibet Qizheng Tibetan Medicine Co., Ltd. won the "Outstanding Award" at the Ram Charan Management Practice Award for its case study on sustainable business models and governance practices [1] Sustainable Business Model - The company emphasizes the importance of biodiversity and natural environment protection in the Qinghai-Tibet Plateau, having completed resource surveys for over 120 Tibetan medicinal materials and established standards for over 60 local varieties [2] - Qizheng has developed a functional base system covering wild nurturing, semi-wild planting, artificial breeding of rare and endangered medicinal materials, and industrialized planting, with a total area exceeding 500,000 acres [2] - The company respects the rights of indigenous people and has established a benefit-sharing mechanism, promoting low-carbon concepts and high-standard green production through smart factories [2] - Qizheng's production process is characterized by low pollution and minimal waste, and it has implemented an environmental management system certified by national standards [2] - The company promotes Tibetan medicine culture through projects like the Qizheng Foundation and the "Hundred Clinics Plan," creating a mutually beneficial ecosystem with stakeholders [2] Sustainable Governance Practices - Since 2012, the company has been systematically building a sustainable development management system, with plans to upgrade its ESG framework by 2025 [3] - Qizheng has established a "Strategic Five Trees" model to link strategy and operational plans seamlessly, covering the entire chain from disease to health, technology, products, and branding [3] - The company enforces a "one-vote veto" system in product development, prohibiting the market introduction of any strategic products relying on endangered or scarce resources without completed resource planning [3] - Qizheng is focused on organizational succession and talent cultivation, promoting a younger workforce and establishing a management foundation centered on modern corporate systems [3] - The founder of Qizheng, Lei Jufang, received the first Peter Drucker Management Award in China for his sustainable development practices in Tibetan medicine [3]

Core Insights - The Ram Charan Management Practice Award recognized Qizheng Tibetan Medicine for its outstanding case study on sustainable business models and governance practices [2][4] - The award highlights Qizheng's innovative approaches in the sustainable development of traditional Chinese medicine and ethnic medicine [2] Company Overview - Qizheng Tibetan Medicine has prioritized biodiversity and environmental protection in the Qinghai-Tibet Plateau [2] - The company has conducted resource surveys on over 120 Tibetan medicinal materials and established standards for more than 60 local varieties [2] - Qizheng has implemented research on cultivation techniques for 58 medicinal materials, creating a functional base system covering over 500,000 acres [2] Environmental Practices - The company actively promotes low-carbon principles and high-standard green production [2] - Qizheng has built an intelligent factory and established an environmental management system covering all production stages [2] Cultural and Educational Initiatives - Through the Qizheng Foundation, the company promotes Tibetan medicine culture via grassroots education and clinic initiatives [3] - Qizheng aims to create a symbiotic business ecosystem with stakeholders [3] Strategic Planning - The company has developed a "Strategic Five Trees" model, linking disease, health, technology, products, and brand for seamless strategic and operational integration [3] - Qizheng enforces a "one-vote veto" system in product development, ensuring that any marketable variety relying on endangered resources is not advanced without proper resource planning [3] Organizational Development - Qizheng is advancing organizational youthfulness and establishing a modern management system to attract and cultivate professional talent [3]

Core Insights - The company, Qizheng Tibetan Medicine, won the "Outstanding Award" at the Ram Charan Management Practice Award for its case study on sustainable business models and governance practices [1][3] - The award highlights the company's innovative approach to sustainable business practices in the traditional Chinese medicine and ethnic medicine sectors [1] Group 1: Sustainable Practices - Qizheng Tibetan Medicine emphasizes biodiversity and environmental protection, having completed resource surveys for over 120 Tibetan medicinal materials and established standards for more than 60 local varieties [1] - The company has conducted research on cultivation techniques for 58 types of Tibetan medicinal materials and developed a functional base system covering over 500,000 acres [1] - The company actively promotes low-carbon principles and high-standard green production, creating smart factories and implementing an environmental management system across all production stages [1] Group 2: Cultural and Strategic Initiatives - Through the Qizheng Foundation, the company promotes Tibetan medicine culture via projects like folk Tibetan medicine education and a clinic initiative, fostering a symbiotic business ecosystem [2] - The company has developed a "Strategic Five Trees" model, linking disease, health, technology, products, and brand to ensure seamless integration of strategy and operational plans [2] - In product development, the company enforces a "one-vote veto" system, prohibiting the market introduction of any potentially viable products that rely on endangered or scarce resources without completed resource planning [2] Group 3: Management and Recognition - The recent award serves as authoritative recognition of the company's sustainable business model and management practices [3] - In 2019, the founder of Qizheng Tibetan Medicine received the inaugural Peter Drucker Management Award in China for her commitment to sustainable development and social responsibility in the Tibetan medicine sector [3]

Core Points - The company has officially announced the transformation of its "Board Strategic Investment Committee" into the "Board Strategic Investment and ESG Committee," integrating ESG principles into its core decision-making framework [1] - This move aligns with recent regulatory requirements and reflects the growing importance of ESG in the pharmaceutical industry, particularly in relation to public health and capital market recognition [1][2] Group 1: Committee Adjustments - The name change emphasizes the equal importance of ESG alongside strategic investment, moving away from the previous perception of ESG as a secondary concern [2] - The committee's responsibilities have expanded to include five core ESG functions, such as developing top-level ESG planning and assessing ESG impacts on significant company matters [2] - The composition and terms of the committee members remain unchanged to ensure continuity in strategic investment decisions while facilitating the quick implementation of ESG responsibilities [2] Group 2: Industry Leadership - The restructuring represents a systematic leap for the company, building on its years of exemplary ESG practices and providing a replicable model for the Tibetan medicine and ethnic medicine sectors [3] - The company has achieved an ESG A-level rating and has received multiple awards for its ESG efforts, including recognition for its social responsibility and sustainable development initiatives [3] - As of the end of 2024, the company's public welfare foundation has invested a total of 169.2 million yuan in charitable activities, demonstrating a long-term commitment to sustainability and transparency in ESG reporting [3]

Core Viewpoint - Qizheng Tibetan Medicine (002287.SZ) reported a revenue of 1.523 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 3.48% [1] - The net profit attributable to shareholders of the listed company reached 424 million yuan, marking a year-on-year increase of 7.66% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 282 million yuan, with a year-on-year growth of 4.21% [1] Financial Performance - Revenue for the first three quarters: 1.523 billion yuan, up 3.48% year-on-year [1] - Net profit attributable to shareholders: 424 million yuan, up 7.66% year-on-year [1] - Net profit after deducting non-recurring gains and losses: 282 million yuan, up 4.21% year-on-year [1]

证券日报网讯奇正藏药（002287）10月27日在互动平台回答投资者提问时表示，截至2025年10月20日， 公司股东总人数为33047户。 ...

西藏奇正藏药股份有限公司 第六届董事会第十四次会议决议公告 证券代码：002287 证券简称：奇正藏药 公告编号：2025-095 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、西藏奇正藏药股份有限公司（以下简称"公司"）第六届董事会第十四次 会议于 2025 年 10 月 27 日以电子通信形式召开； 2、会议通知于 2025 年 10 月 22 日以电子邮件、电话、信息等方式发出； 3、会议应参加表决董事 7 人，实际参加表决董事 7 人，其中独立董事 3 名， 公司监事及高级管理人员列席了会议； 4、会议由公司董事长刘凯列先生召集并主持； 二、董事会会议审议情况 1、审议通过了《2025 年第三季度报告》； 2025 年前三季度，公司实现营业收入 152,294.38 万元，较上年同期增长 3.48%；公司实现归属于上市公司股东的净利润 42,351.90 万元，较上年同期增 长 7.66%；实现归属于上市公司股东的扣除非经常性损益的净利润 28,192.81 万 元，较上年同期增长 4.21%。详见 2025 年 10 月 ...

Core Insights - The company reported a third-quarter revenue of 348 million, representing a decline of 24.69% compared to the previous year [1] - The net profit for the third quarter was 65.12 million, down 3.79% year-over-year [1] - For the first three quarters, the company achieved a revenue of 1.523 billion, an increase of 3.48% compared to the same period last year [1] - The net profit for the first three quarters was 424 million, reflecting a growth of 7.66% year-over-year [1]